Motley Fool Money cover image

Surging Oil Prices Spark Market Jitters

Motley Fool Money

00:00

Hims & Hers' Novo Nordisk Deal

Rachel details the partnership ending legal risk: Hims will sell Novo's GLP-1 drugs, shifting from copycats to approved products.

Play episode from 16:29
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app